Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Peripheral Arterial Disease: Features

Dr. Goueffic
LINC 2022
EMINENT DES vs BMS trial: 12-month Primary Endpoint Data and Subset Analysis
06/09/2022
Dr. Yann Gouëffic presented included 1-year results from the EMINENT trial of 775 patients, making it the largest randomized industrial trial of a drug-eluting stent for the treatment of peripheral arterial disease to date.
Dr. Yann Gouëffic presented included 1-year results from the EMINENT trial of 775 patients, making it the largest randomized industrial trial of a drug-eluting stent for the treatment of peripheral arterial disease to date.
Dr. Yann Gouëffic presented...
06/09/2022
Vascular Disease Management
Study Overview
First-Time Data Release/LINC 2022
Long-term Evidence of Directional Atherectomy and DCB: 3-Year Clinical Experience from Australia
06/07/2022
Dr. VIkram Puttaswamy discusses the results of a 3-year clinical study of long-term use of directional atherectomy and drug-coated balloons.
Dr. VIkram Puttaswamy discusses the results of a 3-year clinical study of long-term use of directional atherectomy and drug-coated balloons.
Dr. VIkram Puttaswamy discusses...
06/07/2022
Vascular Disease Management
UltraScore Study Results
First-Time Data Release/LINC 2022
UltraScore: Final Results of a Multi-Center Study
06/07/2022
Dr. Robert Beasley discusses the results of a 12-month study of the clinical use of the UltraScore balloon in a real-world, on-label, clinical application.
Dr. Robert Beasley discusses the results of a 12-month study of the clinical use of the UltraScore balloon in a real-world, on-label, clinical application.
Dr. Robert Beasley discusses the...
06/07/2022
Vascular Disease Management
Interview and Case Report
Broaden Access Options With the Longer Shockwave M5+ 135cm Catheter
06/01/2022
VDM speaks with interventional cardiologist Amit Srivastava, MD, from Bay Area Heart Cardiac, Vascular, and Vein Center.
VDM speaks with interventional cardiologist Amit Srivastava, MD, from Bay Area Heart Cardiac, Vascular, and Vein Center.
VDM speaks with interventional...
06/01/2022
Vascular Disease Management
Video
Avoiding Potential Complications With Peripheral Arterial Interventions via Radial Artery Access
05/18/2022
Dr. Walker discusses his Editor's Corner article.
Dr. Walker discusses his Editor's Corner article.
Dr. Walker discusses his...
05/18/2022
Vascular Disease Management
Original Research
Edetate Disodium Infusions May Benefit Patients With Diabetes and Critical Limb-Threatening Ischemia
05/16/2022
Outcomes of CLTI patients with diabetes who underwent edetate disodium-based infusions.
Outcomes of CLTI patients with diabetes who underwent edetate disodium-based infusions.
Outcomes of CLTI patients with...
05/16/2022
Vascular Disease Management
Perspectives
April Is Limb Loss and Limb Difference Awareness Month: Six Limb-Saving Lessons Learned by Physicians Recognized as PAD Patient Champions
04/30/2022
Stopping amputations.
Stopping amputations.
Stopping amputations.
04/30/2022
Vascular Disease Management
Clinical Images
Negotiating Transcatheter Aortic Valve Replacement in Severe Peripheral Arterial Disease
03/14/2022
Performing TAVR on a 73-year-old man with a EuroSCORE II of 12%.
Performing TAVR on a 73-year-old man with a EuroSCORE II of 12%.
Performing TAVR on a 73-year-old...
03/14/2022
Vascular Disease Management
Dr. Christopher Zarins
Video
Improved 3-Year Survival in CLTI Patients With FFRct-Guided Revascularization of Silent Coronary Ischemia
02/22/2022
Dr. Christopher Zarins discusses how the survival of patients with CLTI can be improved in this video from ISET 2022.
Dr. Christopher Zarins discusses how the survival of patients with CLTI can be improved in this video from ISET 2022.
Dr. Christopher Zarins discusses...
02/22/2022
Vascular Disease Management
Dr. Marianne Brodmann
Video
RANGER II SFA Randomized Trial: Results in Women, Patients With Occlusions, and Severe Calcifications
02/22/2022
Dr. Marianne Brodmann discusses the results of the RANGER II SFA Randomized Trial in Women, Patients With Occlusions, and Severe Calcifications in this video from ISET 2022. 
Dr. Marianne Brodmann discusses the results of the RANGER II SFA Randomized Trial in Women, Patients With Occlusions, and Severe Calcifications in this video from ISET 2022. 
Dr. Marianne Brodmann discusses...
02/22/2022
Vascular Disease Management

Advertisement

Advertisement

Stay in the Know

Vascular Disease Management Newsletter

Advertisement

Advertisement

News

First Aid guidelines
AHA/American Red Cross: Updated First Aid Guidelines Enhance Care for Opioid Overdose, Bleeding, Other Emergencies
11/14/2024
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major...
11/14/2024
Cath Lab Digest
Late-Breaking Trials
Final Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/06/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a...
11/06/2024
Vascular Disease Management
Late-Breaking Trials
Third Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/05/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/05/2024
Vascular Disease Management
Late-Breaking Trials
Second Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Late-Breaking Trials
First Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Image-Guided Therapy
Philips Enrolls First Patient in U.S. Clinical Trial for Innovative Integrated Single-Device to Treat Peripheral Artery Disease
11/04/2024
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first...
11/04/2024
Vascular Disease Management
Pulmonary Embolism
Akura Medical Secures FDA Approval for US Pivotal Trial in Pulmonary Embolism
11/04/2024
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate...
11/04/2024
Vascular Disease Management
Peripheral Arterial Disease
FDA Grants R3 Vascular IDE Approval for ELITE-BTK Pivotal Trial of its MAGNITUDE® Drug Eluting Next Generation Bioresorbable Scaffold for Below-the-Knee Peripheral Arterial Disease
11/04/2024
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November...
11/04/2024
Vascular Disease Management
Patient Awareness
Baby Boomers Beware: More Americans Than Ever Before Now at Higher Risk for Common Blood Vessel Diseases
10/31/2024
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in...
10/31/2024
Vascular Disease Management
DCB
SIRONA Trial @TCT – First Head-to-Head Comparison of Sirolimus Versus Paclitaxel DCBs in the Treatment of PAD: Sirolimus-Coated Balloons Yield Similar Results to Paclitaxel-Coated Balloons in the Femoropopliteal Artery
10/30/2024
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective,...
10/30/2024
Cath Lab Digest

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement